The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Performance of Pharmacovigilance Signal-Detection Algorithms for the FDA Adverse Event Reporting System
Open accessAbstract
Signal-detection algorithms (SDAs) are recognized as vital tools in pharmacovigilance. However, their performance characteristics are generally unknown. By leveraging a unique gold standard recently made public by the Observational Medical Outcomes Partnership (OMOP) and by conducting a unique systematic evaluation, we provide new insights into the diagnostic potential and characteristics of SDAs that are routinely applied to the US Food and Drug Administration (FDA) Adverse Event Reporting System (AERS). We find that SDAs can attain reasonable predictive accuracy in signaling adverse events. Two performance classes emerge, indicating that the class of approaches that address confounding and masking effects benefits safety surveillance. Our study shows that not all events are equally detectable, suggesting that specific events might be monitored more effectively using other data sources. We provide performance guidelines for several operating scenarios to inform the trade-off between sensitivity and specificity for specific use cases. We also propose an approach and demonstrate its application in identifying optimal signaling thresholds, given specific misclassification tolerances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening
Pisano, E. D., Gatsonis, C., Hendrick, E., Yaffe, M., Baum, J. K., Acharyya, S., Conant, E. F., Fajardo, L. L., Bassett, L., D'Orsi, C., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa052911 · Cited by 1,940
Evans, S. J. W., Waller, P. C., & Davis, S. (2001) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.677 · Cited by 1,802
Perkins, N. J., & Schisterman, E. F. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj063 · Cited by 1,759
van Puijenbroek, E. P., Bate, A., Leufkens, H. G. M., Lindquist, M., Orre, R., & Egberts, A. C. G. (2002) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.668 · Cited by 1,372
Quantitative signal detection using spontaneous ADR reporting
Bate, A., & Evans, S. J. W. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1742 · Cited by 912
Dumouchel, W. (1999) · The American Statistician · doi:10.1080/00031305.1999.10474456 · Cited by 878
Self-citationSzarfman, A., Machado, S. G., & O??Neill, R. T. (2002) · Drug Safety · doi:10.2165/00002018-200225060-00001 · Cited by 700
Stang, P. E., Ryan, P. B., Racoosin, J. A., Overhage, J. M., Hartzema, A. G., Reich, C., Welebob, E., Scarnecchia, T., & Woodcock, J. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-9-201011020-00010 · Cited by 441
Self-citationNovel Data-Mining Methodologies for Adverse Drug Event Discovery and Analysis
Harpaz, R., DuMouchel, W., Shah, N. H., Madigan, D., Ryan, P., & Friedman, C. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.50 · Cited by 393
Self-citationThe role of data mining in pharmacovigilance
Hauben, M., Madigan, D., Gerrits, C. M., Walsh, L., & Van Puijenbroek, E. P. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.5.929 · Cited by 276
Novel Statistical Tools for Monitoring the Safety of Marketed Drugs
Almenoff, J. S., Pattishall, E. N., Gibbs, T. G., DuMouchel, W., Evans, S. J. W., & Yuen, N. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100258 · Cited by 266
Self-citationA basic study design for expedited safety signal evaluation based on electronic healthcare data
Schneeweiss, S. (2010) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1926 · Cited by 255
Perspectives on the Use of Data Mining in Pharmacovigilance
Almenoff, J., Tonning, J. M., Gould, A. L., Szarfman, A., Hauben, M., Ouellet-Hellstrom, R., Ball, R., Hornbuckle, K., Walsh, L., Yee, C., et al. (2005) · Drug Safety · doi:10.2165/00002018-200528110-00002 · Cited by 250
The New Sentinel Network — Improving the Evidence of Medical-Product Safety
Platt, R., Wilson, M., Chan, K. A., Benner, J. S., Marchibroda, J., & McClellan, M. (2009) · New England Journal of Medicine · doi:10.1056/nejmp0905338 · Cited by 228
Trifirò, G., Pariente, A., Coloma, P. M., Kors, J. A., Polimeni, G., Miremont‐Salamé, G., Catania, M. A., Salvo, F., David, A., Moore, N., et al. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1836 · Cited by 183
Ryan, P. B., Madigan, D., Stang, P. E., Marc Overhage, J., Racoosin, J. A., & Hartzema, A. G. (2012) · Statistics in Medicine · doi:10.1002/sim.5620 · Cited by 179
Self-citationHartnell, N. R., & Wilson, J. P. (2004) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.8.743.36068 · Cited by 172
Decision support methods for the detection of adverse events in post-marketing data
Hauben, M., & Bate, A. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2008.12.012 · Cited by 163
Data mining for signals in spontaneous reporting databases: proceed with caution
Stephenson, W. P., & Hauben, M. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1323 · Cited by 147
Pharmacovigilance in the 21st Century: New Systematic Tools for an Old Problem
Szarfman, A., Tonning, J. M., & Doraiswamy, P. M. (2004) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.24.13.1099.38090 · Cited by 126
Statin safety: an appraisal from the adverse event reporting system
Davidson, M. H., Clark, J. A., Glass, L. M., & Kanumalla, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.008 · Cited by 113
Comparative Performance of Two Quantitative Safety Signalling Methods
Almenoff, J. S., LaCroix, K., Yuen, N., Fram, D. M., & DuMouchel, W. (2006) · Drug Safety · doi:10.2165/00002018-200629100-00005 · Cited by 110
Self-citationBrown, E. G. (2003) · Drug Safety · doi:10.2165/00002018-200326030-00002 · Cited by 110
Comparison of data mining methodologies using Japanese spontaneous reports
Kubota, K., Koide, D., & Hirai, T. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.964 · Cited by 103
A Likelihood Ratio Test Based Method for Signal Detection With Application to FDA’s Drug Safety Data
Huang, L., Zalkikar, J. N., & Tiwari, R. C. (2011) · Journal of the American Statistical Association · doi:10.1198/jasa.2011.ap10243 · Cited by 101
Appraisal of the MedDRA Conceptual Structure for Describing and Grouping Adverse Drug Reactions
Cédric Bousquet, B., Lagier, G., Louët, A. L., Beller, C. L., Alain Venot, A., & Jaulent, M. (2005) · Drug Safety · doi:10.2165/00002018-200528010-00002 · Cited by 97
Alvarez, Y., Hidalgo, A. A. T., Maignen, F. M., & Slattery, J. (2010) · Drug Safety · doi:10.2165/11534410-000000000-00000 · Cited by 89
Comparing data mining methods on the VAERS database
Banks, D., Woo, E. J., Burwen, D. R., Perucci, P., Braun, M. M., & Ball, R. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1107 · Cited by 79
Impact of Stratification on Adverse Drug Reaction Surveillance
Hopstadius, J., Norén, G. N., Bate, A., & Edwards, I. R. (2008) · Drug Safety · doi:10.2165/00002018-200831110-00008 · Cited by 59
An Evaluation of Three Signal-Detection Algorithms Using a Highly Inclusive Reference Event Database
Hochberg, A. M., Hauben, M., Pearson, R. K., O’Hara, D. J., Reisinger, S. J., Goldsmith, D. I., Gould, A. L., & Madigan, D. (2009) · Drug Safety · doi:10.2165/00002018-200932060-00007 · Cited by 47
Hauben, M., & Reich, L. (2005) · The Journal of Clinical Pharmacology · doi:10.1177/0091270004273936 · Cited by 41
Using Data Mining to Predict Safety Actions from FDA Adverse Event Reporting System Data
Hochberg, A. M., Reisinger, S. J., Pearson, R. K., O’Hara, D. J., & Hall, K. (2007) · Drug Information Journal · doi:10.1177/009286150704100510 · Cited by 37
An Evaluation of Computer-Aided Disproportionality Analysis for Post-Marketing Signal Detection
Lehman, H. P., Chen, J., Gould, A. L., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100233 · Cited by 28
(1950) · doi:10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3
Cited by
Fusaroli, M., Salvo, F., Begaud, B., AlShammari, T. M., Bate, A., Battini, V., Brueckner, A., Candore, G., Carnovale, C., Crisafulli, S., et al. (2024) · Drug Safety · doi:10.1007/s40264-024-01423-7 · Cited by 351
Noguchi, Y., Tachi, T., & Teramachi, H. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab347 · Cited by 285
Hoffman, K. B., Dimbil, M., Erdman, C. B., Tatonetti, N. P., & Overstreet, B. M. (2014) · Drug Safety · doi:10.1007/s40264-014-0150-2 · Cited by 211
Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems
Cutroneo, P. M., Sartori, D., Tuccori, M., Crisafulli, S., Battini, V., Carnovale, C., Rafaniello, C., Capuano, A., Poluzzi, E., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation · doi:10.3389/fdsfr.2023.1323057 · Cited by 224
Raschi, E., Gatti, M., Gelsomino, F., Ardizzoni, A., Poluzzi, E., & De Ponti, F. (2020) · Targeted Oncology · doi:10.1007/s11523-020-00738-6 · Cited by 157
Metadata
- Authors
- Harpaz, R., DuMouchel, W., LePendu, P., Bauer-Mehren, A., Ryan, P., & Shah, N. H.
- Venue
- Clinical Pharmacology & Therapeutics
- Publisher
- Wiley
- Published
- 2013-02-11
- Volume
- 93
- Issue
- 6
- Pages
- 539-546
- ISSN
- 0009-9236 (ISSN-L)
- 1532-6535
- OpenAlex
- W2107516065
- Cited by
- 333
- References
- 35
- FWCI
- 31.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.